Patents by Inventor Robert A. Clare

Robert A. Clare has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosage regimen for MAdCAM antagonists
    Patent number: 11884726
    Abstract: The present invention provides a method for the treatment of a patient comprising administering to the patient an initial dose of between about 1 mg and about 150 mg of a MAdCAM antagonist antibody. Biomarkers for assessing a patient's response to anti-MAdCAM treatment are also provided.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: January 30, 2024
    Assignee: Pfizer Inc.
    Inventors: Fabio Cataldi, Robert A. Clare, Gail M. Comer, Vivekananda Pradhan, Alaa Ahmad, Mina Hassan-Zahraee, Mera Krishnan Tilley, Weidong Zhang, Anindita Banerjee, Karen Michelle Page, Michael Steven Vincent, David J. Von Schack
  • Dosage Regimen For MAdCAM Antagonists
    Publication number: 20210324070
    Abstract: The present invention provides a method for the treatment of a patient comprising administering to the patient an initial dose of between about 1 mg and about 150 mg of a MAdCAM antagonist antibody. Biomarkers for assessing a patient's response to anti-MAdCAM treatment are also provided.
    Type: Application
    Filed: November 30, 2020
    Publication date: October 21, 2021
    Inventors: Fabio CATALDI, Robert A. CLARE, Gail M. COMER, Vivekananda PRADHAN, Alaa AHMAD, Mina HASSAN-ZAHRAEE, Mera Krishnan TILLEY, Weidong ZHANG, Anindita BANERJEE, Karen Michelle PAGE, Michael Steven VINCENT, David J. VON SCHACK
  • Dosage regimen for MAdCAM antagonists
    Patent number: 10851163
    Abstract: The present invention provides a method for the treatment of a patient comprising administering to the patient an initial dose of between about 1 mg and about 150 mg of a MAdCAM antagonist antibody. Biomarkers for assessing a patient's response to anti-MAdCAM treatment are also provided.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: December 1, 2020
    Assignee: PFIZER INC.
    Inventors: Fabio Cataldi, Robert A. Clare, Gail M. Comer, Vivekananda Pradhan, Alaa Ahmad, Mina Hassan-Zahraee, Mera Krishnan Tilley, Weidong Zhang, Anindita Banerjee, Karen Michelle Page, Michael Steven Vincent, David J. Von Schack
  • DOSAGE REGIMEN FOR MADCAM ANTAGONISTS
    Publication number: 20180273619
    Abstract: The present invention provides a method for the treatment of a patient comprising administering to the patient an initial dose of between about 1 mg and about 150 mg of a MAdCAM antagonist antibody. Biomarkers for assessing a patient's response to anti-MAdCAM treatment are also provided.
    Type: Application
    Filed: January 6, 2016
    Publication date: September 27, 2018
    Inventors: Fabio CATALDI, Robert A. CLARE, Gail M. COMER, Vivekananda PRADHAN, Alaa AHMAD, Mina HASSAN-ZAHRAEE, Mera Krishnan TILLEY, Weidong ZHANG, Anindita BANERJEE, Karen Michelle PAGE, Michael Steven VINCENT, David J. VON SCHACK
  • Continuous cell line and vaccine against avian coccidia
    Patent number: 5846527
    Abstract: A non-lymphoid continuous cell line adapted for propagation of avian coccidia is provided. This cell line is useful for the production of vaccine antigenes for prophylactic treatment of poultry, particularly in a novel vaccine for coccidia.
    Type: Grant
    Filed: April 30, 1997
    Date of Patent: December 8, 1998
    Assignee: Pfizer Inc
    Inventors: Timothy J. Miller, Robert A. Clare, Patricia Lufburrow
  • Continuous cell line and vaccine against avian coccidia
    Patent number: 5674484
    Abstract: A non-lymphoid continuous cell line adapted for propagation of avian coccidia is provided. This cell line is useful for the production of vaccine antigens for prophylactic treatment of poultry, particularly in a vaccine for coccidia.
    Type: Grant
    Filed: July 11, 1994
    Date of Patent: October 7, 1997
    Assignee: Pfizer Inc.
    Inventors: Timothy J. Miller, Robert A. Clare, Patricia Lufburrow